Podcast
Questions and Answers
What is the volume of distribution (V) of carbamazepine based on oral administered data?
What is the volume of distribution (V) of carbamazepine based on oral administered data?
- 2.3L/kg
- 1.4L/kg (correct)
- 0.8L/kg
- 1.9L/kg
What is the maintenance dose adjustment interval for carbamazepine?
What is the maintenance dose adjustment interval for carbamazepine?
- Every 3-4 weeks
- Every 6-8 weeks
- Every 1-2 weeks (correct)
- Every month
What is the half-life (t 1/2) of carbamazepine in adult patients receiving polytherapy?
What is the half-life (t 1/2) of carbamazepine in adult patients receiving polytherapy?
- $12$ hours
- $10$ hours (correct)
- $8$ hours
- $15$ hours
What is the therapeutic range for plasma concentration of carbamazepine?
What is the therapeutic range for plasma concentration of carbamazepine?
What is the free fraction (α) of carbamazepine in plasma?
What is the free fraction (α) of carbamazepine in plasma?
What is the effective dose range for seizure disorders?
What is the effective dose range for seizure disorders?
Which enzyme is responsible for the metabolism of the drug?
Which enzyme is responsible for the metabolism of the drug?
What is the ratio of carbamazepine-10,11-epoxide to carbamazepine in infants and preschool children compared to adults?
What is the ratio of carbamazepine-10,11-epoxide to carbamazepine in infants and preschool children compared to adults?
What percentage of an oral dose of carbamazepine is excreted unchanged in urine?
What percentage of an oral dose of carbamazepine is excreted unchanged in urine?
What may affect the therapeutic range of the drug?
What may affect the therapeutic range of the drug?
In adult patients who have received the drug chronically, what is the average clearance value?
In adult patients who have received the drug chronically, what is the average clearance value?
What happens to clearance in patients who are taking other enzyme inducing antiepileptic drugs concurrently?
What happens to clearance in patients who are taking other enzyme inducing antiepileptic drugs concurrently?
What factor may require an increase in dose for reaching blood circulation in oral form?
What factor may require an increase in dose for reaching blood circulation in oral form?
What occurs when a drug induces its own metabolism?
What occurs when a drug induces its own metabolism?
What is the clearance value in children compared to adults?
What is the clearance value in children compared to adults?
How much of the drug is bound to plasma albumin and α1 –acid glycoprotein?
How much of the drug is bound to plasma albumin and α1 –acid glycoprotein?
How much of the drug is excreted unchanged in urine?
How much of the drug is excreted unchanged in urine?
What is the effective dose range for seizure disorders?
What is the effective dose range for seizure disorders?
Which enzyme is responsible for metabolizing the drug?
Which enzyme is responsible for metabolizing the drug?
In which age group is the formation of carbamazepine-10,11-epoxide higher compared to adults?
In which age group is the formation of carbamazepine-10,11-epoxide higher compared to adults?
What percentage of the oral dose of carbamazepine is excreted unchanged in urine?
What percentage of the oral dose of carbamazepine is excreted unchanged in urine?
Which protein is the drug bound to in plasma?
Which protein is the drug bound to in plasma?
What happens to clearance values when patients are taking other enzyme-inducing antiepileptic drugs concurrently?
What happens to clearance values when patients are taking other enzyme-inducing antiepileptic drugs concurrently?
What factor affects the bioavailability of the drug in oral form?
What factor affects the bioavailability of the drug in oral form?
What does alteration in serum protein concentration affect?
What does alteration in serum protein concentration affect?
What does alteration in serum protein concentration affect?
What does alteration in serum protein concentration affect?
What is the volume of distribution (V) of carbamazepine?
What is the volume of distribution (V) of carbamazepine?
What is the reported steady-state half-life range for carbamazepine?
What is the reported steady-state half-life range for carbamazepine?
What is the half-life (t 1/2) of Carbamazepine in adult patients receiving monotherapy?
What is the half-life (t 1/2) of Carbamazepine in adult patients receiving monotherapy?
What is the therapeutic range of plasma concentration for Carbamazepine?
What is the therapeutic range of plasma concentration for Carbamazepine?
What is the free fraction of Carbamazepine in plasma?
What is the free fraction of Carbamazepine in plasma?
What effect does autoinduction commonly cause in steady-state carbamazepine levels?
What effect does autoinduction commonly cause in steady-state carbamazepine levels?
When do clinicians prefer to take plasma samples for carbamazepine level monitoring?
When do clinicians prefer to take plasma samples for carbamazepine level monitoring?
What is the bioavailability factor (F) of controlled release products of carbamazepine in suspension?
What is the bioavailability factor (F) of controlled release products of carbamazepine in suspension?
What is the most sensible time for taking plasma samples to reflect trough concentration for carbamazepine level monitoring?
What is the most sensible time for taking plasma samples to reflect trough concentration for carbamazepine level monitoring?
What are some examples of CYP 3A4 inducers that decrease plasma carbamazepine levels?
What are some examples of CYP 3A4 inducers that decrease plasma carbamazepine levels?
What are some adverse effects associated with Carbamazepine?
What are some adverse effects associated with Carbamazepine?
What is the bioavailability factor (F) of controlled release carbamazepine products compared to suspension?
What is the bioavailability factor (F) of controlled release carbamazepine products compared to suspension?
What is the volume of distribution (V) of carbamazepine based on oral administered data?
What is the volume of distribution (V) of carbamazepine based on oral administered data?
What is the maintenance dose adjustment interval for carbamazepine?
What is the maintenance dose adjustment interval for carbamazepine?
What are some examples of CYP 3A4 inducers that decrease plasma carbamazepine levels?
What are some examples of CYP 3A4 inducers that decrease plasma carbamazepine levels?
What is the therapeutic range for plasma concentration for Carbamazepine?
What is the therapeutic range for plasma concentration for Carbamazepine?
What factor may require an increase in dose for reaching blood circulation in oral form?
What factor may require an increase in dose for reaching blood circulation in oral form?
What is the most sensible time for taking plasma samples to reflect trough concentration for carbamazepine level monitoring?
What is the most sensible time for taking plasma samples to reflect trough concentration for carbamazepine level monitoring?
What happens to clearance values when patients are taking other enzyme-inducing antiepileptic drugs concurrently?
What happens to clearance values when patients are taking other enzyme-inducing antiepileptic drugs concurrently?
What factor may affect the therapeutic range of the drug?
What factor may affect the therapeutic range of the drug?
What is the free fraction (α) of carbamazepine in plasma?
What is the free fraction (α) of carbamazepine in plasma?
What is the bioavailability of carbamazepine when administered orally?
What is the bioavailability of carbamazepine when administered orally?
What is the average clearance value of carbamazepine in adults?
What is the average clearance value of carbamazepine in adults?
What is the reported steady-state half-life range for carbamazepine in children on monotherapy?
What is the reported steady-state half-life range for carbamazepine in children on monotherapy?
What factor affects the bioavailability of carbamazepine in oral form?
What factor affects the bioavailability of carbamazepine in oral form?
What is the most sensible time for taking plasma samples to reflect trough concentration for carbamazepine level monitoring?
What is the most sensible time for taking plasma samples to reflect trough concentration for carbamazepine level monitoring?
What enzyme is responsible for metabolizing carbamazepine?
What enzyme is responsible for metabolizing carbamazepine?
Which drug is mentioned as a chemically similar alternative to carbamazepine with an improved safety profile?
Which drug is mentioned as a chemically similar alternative to carbamazepine with an improved safety profile?
What is the bioavailability of carbamazepine when administered orally?
What is the bioavailability of carbamazepine when administered orally?
What is the volume of distribution (V) of carbamazepine?
What is the volume of distribution (V) of carbamazepine?
What is the average clearance value of carbamazepine in adults?
What is the average clearance value of carbamazepine in adults?
What is the reported steady-state half-life range for carbamazepine in children on monotherapy?
What is the reported steady-state half-life range for carbamazepine in children on monotherapy?
What are the limitations of carbamazepine therapy?
What are the limitations of carbamazepine therapy?
What factor affects the therapeutic range of carbamazepine?
What factor affects the therapeutic range of carbamazepine?
What happens to clearance values when patients are taking other enzyme-inducing antiepileptic drugs concurrently?
What happens to clearance values when patients are taking other enzyme-inducing antiepileptic drugs concurrently?
What protein is carbamazepine primarily bound to in plasma?
What protein is carbamazepine primarily bound to in plasma?
Which drug is mentioned as a chemically similar alternative to carbamazepine with an improved safety profile?
Which drug is mentioned as a chemically similar alternative to carbamazepine with an improved safety profile?
When should plasma sampling be done for monitoring carbamazepine levels?
When should plasma sampling be done for monitoring carbamazepine levels?
Study Notes
Carbamazepine Pharmacokinetics and Clinical Considerations
- Therapeutic plasma concentration for carbamazepine: 4-12 mg/L; toxicity symptoms at >9 mg/L; preferred range of 4-8 mg/L.
- Carbamazepine drug interactions: CYP 3A4 inhibitors increase plasma levels; inducers decrease levels.
- Adverse drug reactions include CNS effects, skin rashes, and hematological side effects.
- Bioavailability of carbamazepine: approximately 0.8 when administered orally; slower absorption and variable bioavailability.
- Volume of distribution: approximately 1.4L/kg, primarily bound to albumin and α1- acid glycoprotein.
- Clearance: exclusively metabolic, with less than 2% excretion unchanged in urine; average value approximately 0.064 L/kg/hr in adults.
- Autoinduction of metabolism by carbamazepine leads to changes in steady-state levels and cross-induction of other anticonvulsants.
- Children metabolize carbamazepine more rapidly than adults, with reported steady-state half-lives of 4-12 hours in children and 15 hours in adults on monotherapy.
- Timing of plasma sampling: within the first few weeks of therapy, preferably in the early morning or before the next dose.
- Limitations of carbamazepine therapy include autoinduction, drug interactions, toxicities, and teratogenicity.
- Oxcarbazepine is a chemically similar alternative to carbamazepine with an improved safety profile.
- Clinical case scenarios provide examples for calculating daily doses and adjusting regimens based on plasma levels.
Carbamazepine Pharmacokinetics and Clinical Considerations
- Therapeutic plasma concentration for carbamazepine: 4-12 mg/L; toxicity symptoms at >9 mg/L; preferred range of 4-8 mg/L.
- Carbamazepine drug interactions: CYP 3A4 inhibitors increase plasma levels; inducers decrease levels.
- Adverse drug reactions include CNS effects, skin rashes, and hematological side effects.
- Bioavailability of carbamazepine: approximately 0.8 when administered orally; slower absorption and variable bioavailability.
- Volume of distribution: approximately 1.4L/kg, primarily bound to albumin and α1- acid glycoprotein.
- Clearance: exclusively metabolic, with less than 2% excretion unchanged in urine; average value approximately 0.064 L/kg/hr in adults.
- Autoinduction of metabolism by carbamazepine leads to changes in steady-state levels and cross-induction of other anticonvulsants.
- Children metabolize carbamazepine more rapidly than adults, with reported steady-state half-lives of 4-12 hours in children and 15 hours in adults on monotherapy.
- Timing of plasma sampling: within the first few weeks of therapy, preferably in the early morning or before the next dose.
- Limitations of carbamazepine therapy include autoinduction, drug interactions, toxicities, and teratogenicity.
- Oxcarbazepine is a chemically similar alternative to carbamazepine with an improved safety profile.
- Clinical case scenarios provide examples for calculating daily doses and adjusting regimens based on plasma levels.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Test your knowledge on carbamazepine dosage forms, effective doses for seizure disorders, metabolism by P450 isozyme CYP3A4, and its anticonvulsant activity. Learn how the formation of carbamazepine-10,11-epoxide differs between infants, preschool children, and adults.
